IFNα activates dormant haematopoietic stem cells in vivo
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Maintenance of the blood system is dependent on dormant haematopoietic stem cells (HSCs) with long-term self-renewal capacity. After injury these cells are induced to proliferate to quickly re-establish homeostasis. The signalling molecules promoting the exit of HSCs out of the dormant stage remain largely unknown. Here we show that in response to treatment of mice with interferon-alpha (IFNalpha), HSCs efficiently exit G(0) and enter an active cell cycle. HSCs respond to IFNalpha treatment by the increased phosphorylation of STAT1 and PKB/Akt (also known as AKT1), the expression of IFNalpha target genes, and the upregulation of stem cell antigen-1 (Sca-1, also known as LY6A). HSCs lacking the IFNalpha/beta receptor (IFNAR), STAT1 (ref. 3) or Sca-1 (ref. 4) are insensitive to IFNalpha stimulation, demonstrating that STAT1 and Sca-1 mediate IFNalpha-induced HSC proliferation. Although dormant HSCs are resistant to the anti-proliferative chemotherapeutic agent 5-fluoro-uracil, HSCs pre-treated (primed) with IFNalpha and thus induced to proliferate are efficiently eliminated by 5-fluoro-uracil exposure in vivo. Conversely, HSCs chronically activated by IFNalpha are functionally compromised and are rapidly out-competed by non-activatable Ifnar(-/-) cells in competitive repopulation assays. Whereas chronic activation of the IFNalpha pathway in HSCs impairs their function, acute IFNalpha treatment promotes the proliferation of dormant HSCs in vivo. These data may help to clarify the so far unexplained clinical effects of IFNalpha on leukaemic cells, and raise the possibility for new applications of type I interferons to target cancer stem cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Chronic pro-inflammatory signaling due to chronic infections or repetitive sterile inflammation, however, has been shown to be detrimental to HSPC self-renewal, promoting loss of quiescence and differentiation [61–65].”
From Clonal hematopoiesis and inflammation – the perpetual cycle (2023) · cites this paper as [63]
In the citing paper
“The isolated effects of individual inflammatory cytokines, including type 1 interferons (IFNa/b) 1-3 , type 2 IFN (IFNg) 4-6 , TNFa 7,8 , and IL-1 9-11 , have been well-documented in mouse hematopoietic development.”
From Type 1 interferon perturbates clonal competition by reshaping human blood development (2026) · cites this paper as [9]
In the citing paper
“multiple different sterile and infection-associated inflammatory stimuli have been shown to provoke primitive hematopoietic stem cells (HSCs) to exit their long-term quiescent state and enter into active proliferation”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“The sterile inflammation that it promotes results in a temporarily discrete hematologic response consisting of transient peripheral blood (PB) cytopenias and a parallel increase in proliferation of long-term HSCs (LT-HSCs), all of which return to homeostatic levels within 4 days”
From Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging (2022) · cites this paper as Essers et al., 2009
In the citing paper
“In addition to IL-6, other cytokines such as IFNα, IFNγ, IL-1α, IL-1β, and TNFα can also directly activate HSCs (Baldridge et al., 2010; Essers et al., 2009; Pietras et al., 2014; Pietras et al., 2016; Sujer, 2014).”
From Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis (2018) · cites this paper as Essers et al., 2009
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Kiel, M. J., Yilmaz, Ö. H., Iwashita, T., Yilmaz, O. H., Terhorst, C., & Morrison, S. J. (2005) · Cell · doi:10.1016/j.cell.2005.05.026 · Cited by 3,168
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Long-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Wilson, A., Laurenti, E., Oser, G., van der Wath, R. C., Blanco-Bose, W., Jaworski, M., Offner, S., Dunant, C. F., Eshkind, L., Bockamp, E., et al. (2008) · Cell · doi:10.1016/j.cell.2008.10.048 · Cited by 1,908
Self-citationInducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Bone-marrow haematopoietic-stem-cell niches
Wilson, A., & Trumpp, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1779 · Cited by 1,354
Self-citationHematopoietic Stem Cell Quiescence Maintained by p21 cip1/waf1
Cheng, T., Rodrigues, N., Shen, H., Yang, Y.-G., Dombkowski, D., Sykes, M., & Scadden, D. T. (2000) · Science · doi:10.1126/science.287.5459.1804 · Cited by 1,339
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,242
Cited by
Items 501–600 of 1,002
Ehninger, A., Boch, T., Uckelmann, H., Essers, M. A., Müdder, K., Sleckman, B. P., & Trumpp, A. (2014) · Blood · doi:10.1182/blood-2013-10-531038 · Cited by 36
“We and others previously demonstrated that interferon-a (IFN-a) is capable of activating dormant HSCs and driving them into the cell cycle.(8,9) Hence, we asked whether IFN-a-induced proliferation is associated with c-Myc induction.”
BackgroundSelf-citationHyperdiploid tumor cells increase phenotypic heterogeneity within Glioblastoma tumors
Donovan, P., Cato, K., Legaie, R., Jayalath, R., Olsson, G., Hall, B. I., Olson, S., Boros, S., Reynolds, B. A., & Harding, A. S. (2014) · Molecular BioSystems · doi:10.1039/c3mb70484j · Cited by 42
Mechanisms of self-renewal in hematopoietic stem cells
Wang, Z., & Ema, H. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1919-5 · Cited by 43
A new frontier in Fanconi anemia: From DNA repair to ribosome biogenesis
Gueiderikh, A., Maczkowiak, F., & Rosselli, F. (2021) · Blood Reviews · doi:10.1016/j.blre.2021.100904 · Cited by 41
Maternal inflammation regulates fetal emergency myelopoiesis
Collins, A., Swann, J. W., Proven, M. A., Patel, C. M., Mitchell, C. A., Kasbekar, M., Dellorusso, P. V., & Passegue, E. A. (2024) · Cell · doi:10.1016/j.cell.2024.02.002 · Cited by 45
MLL1 and DOT1L cooperate with meningioma-1 to induce acute myeloid leukemia
Riedel, S. S., Haladyna, J. N., Bezzant, M., Stevens, B. M., Pollyea, D. A., Sinha, A. U., Armstrong, S. A., Wei, Q., Pollock, R. M., Daigle, S. R., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80825 · Cited by 41
“However, these effects were resolved after 5 days (26), and flowcytometric analysis of pI:pC-injected animals performed 6 days after the last dose showed a clearly distinguishable LSK population (Supplemental Figure 1C).”
BackgroundExtracellular matrix protein Matrilin-4 regulates stress-induced HSC proliferation via CXCR4
Uckelmann, H., Blaszkiewicz, S., Nicolae, C., Haas, S., Schnell, A., Wurzer, S., Wagener, R., Aszodi, A., & Essers, M. A. G. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151713 · Cited by 39
Self-citationQin, Y., & Zhang, C. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9761-1 · Cited by 41
Barbieri, D., Elvira‐Matelot, E., Pelinski, Y., Genève, L., de Laval, B., Yogarajah, G., Pecquet, C., Constantinescu, S. N., & Porteu, F. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20170997 · Cited by 44
“Chronic IFN-I exposure in vivo has been shown to induce transient HSC proliferation and/or apoptosis (Essers et al., 2009; Pietras et al., 2014), whereas THPO is required for HSC maintenance through regulation of survival, quiescence, or self-renewal divisions and favors transplantation (Qian et…”
BackgroundInfluentialThe chromatin-binding protein Phf6 restricts the self-renewal of hematopoietic stem cells
Miyagi, S., Sroczyńska, P., Kato, Y., Nakajima‐Takagi, Y., Oshima, M., Rizq, O., Takayama, N., Saraya, A., Mizuno, S., Sugiyama, F., et al. (2019) · Blood · doi:10.1182/blood.2019000468 · Cited by 40
Yap1-Scribble polarization is required for hematopoietic stem cell division and fate
Althoff, M. J., Nayak, R. C., Hegde, S., Wellendorf, A. M., Bohan, B., Filippi, M., Xin, M., Lu, Q. R., Geiger, H., Zheng, Y., et al. (2020) · Blood · doi:10.1182/blood.2019004113 · Cited by 41
Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms
Brkić, Š., & Meyer, S. C. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000516 · Cited by 47
“IFN α appears to activate dormant HSCs in mice inducing exhaustion 84 and elimination of Jak2 V617F + MPN-propagating stem cells.”
Bcl‐2 proteins in development, health, and disease of the hematopoietic system
Kollek, M., Müller, A., Egle, A., & Erlacher, M. (2016) · FEBS Journal · doi:10.1111/febs.13683 · Cited by 42
Pten loss in the bone marrow leads to G-CSF–mediated HSC mobilization
Tesio, M., Oser, G. M., Baccelli, I., Blanco-Bose, W., Wu, H., Göthert, J. R., Kogan, S. C., & Trumpp, A. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20122768 · Cited by 35
“Stress-induced cytokines, including type I and II IFNs and G-CSF, all promote dormant HSCs to enter an active cell cycle mode (Tothova and Gilliland, 2007; Wilson et al., 2008; Essers et al., 2009; Baldridge et al., 2010).”
BackgroundSelf-citationHematopoietic niches, erythropoiesis and anemia of chronic infection
Gomes, A. C., & Gomes, M. S. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.11.007 · Cited by 41
Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation
Sezaki, M., Hayashi, Y., Wang, Y., Johansson, A., Umemoto, T., & Takizawa, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585367 · Cited by 43
Li, J., Williams, M., Park, H. J., Bastos, H. P., Wang, X., Prins, D., Wilson, N. K., Johnson, C., Sham, K., Wantoch, M., et al. (2022) · Blood · doi:10.1182/blood.2021014009 · Cited by 41
The Chronic Myeloid Leukemia Stem Cell
Nicholson, E., & Holyoake, T. L. (2009) · Clinical Lymphoma & Myeloma · doi:10.3816/clm.2009.s.037 · Cited by 42
Chen, D.-W., Fan, J., Schrey, J. M., Mitchell, D. V., Jung, S. K., Hurwitz, S. N., Pérez, E. B., Muraro, M. J., Carroll, M. P., Taylor, D. M., et al. (2024) · Leukemia · doi:10.1038/s41375-024-02136-7 · Cited by 39
“To investigate the involvement of miR-155 in EV AML , we assayed miR-155 levels in HSPCs following EV AML and found elevated mR-155 levels in HSPCs at 24 and 48 h post C1498-and AF9-EV AML (Supplementary Fig.”
Forged in the fire: Lasting impacts of inflammation on hematopoietic progenitors
Cao, R., Thatavarty, A., & King, K. Y. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104215 · Cited by 39
Tsuzuki, S., & Seto, M. (2011) · Blood · doi:10.1182/blood-2011-06-362277 · Cited by 37
Akhter, S., Rahman, M. M., Lee, H. S., Kim, H., & Hong, S. (2013) · Protein & Cell · doi:10.1007/s13238-013-2066-5 · Cited by 38
“This self-renewal feature is essential for their expansion throughout hematopoietic development, hematopoietic homeostasis, after bone marrow (BM) transplantation and/or in response to different physiologic stresses (Wilson et al., 2008; Essers et al., 2009).”
BackgroundThe plasticity of inflammatory monocyte responses to the inflamed central nervous system
Ashhurst, T. M., van Vreden, C., Niewold, P., & King, N. J. C. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.07.002 · Cited by 40
“On the other hand, in experimental autoimmune encephalomyelitis (EAE), GM-CSF produced by CNS cells triggers monocyte mobilisation and emigration from the BM [20] .”
BackgroundSignal transduction pathways, intrinsic regulators, and the control of cell fate choice
Fossett, N. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.06.005 · Cited by 42
Li, G., Zhao, J., Cheng, L., Jiang, Q., Kan, S., Qin, E., Tu, B., Zhang, X., Zhang, L., Su, L., et al. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006505 · Cited by 37
Jassinskaja, M., Johansson, E., Kristiansen, T. A., Åkerstrand, H., Sjöholm, K., Hauri, S., Malmström, J. A., Yuan, J., & Hansson, J. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.11.070 · Cited by 45
Wang, J., Saijo, K., Skola, D., Jin, C., Ma, Q., Merkurjev, D., Glass, C. K., & Rosenfeld, M. G. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718759114 · Cited by 38
Leukemia Stem Cell Release From the Stem Cell Niche to Treat Acute Myeloid Leukemia
Villatoro, A., Konieczny, J., Cuminetti, V., & Arranz, L. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00607 · Cited by 39
“Acute IFN-α treatment in vivo promotes proliferation of dormant HSC and makes them sensitive to 5-fluoro-uracil, whereas chronic activation of the IFN-α pathway in HSC impairs their function (Essers et al., 2009).”
BackgroundDirect and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow
Xiong, F., Wang, Q., Wu, G., Liu, W., Wang, B., & Chen, Y. (2022) · Biomarker Research · doi:10.1186/s40364-022-00415-y · Cited by 38
Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming
Jacobs, K., Doerdelmann, C., Krietsch, J., González‐Acosta, D., Mathis, N., Kushinsky, S., Guarino, E., Gómez‐Escolar, C., Martínez, D., Schmid, J. A., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.09.009 · Cited by 37
Roeder, I., Loeffler, M., & Glauche, I. (2011) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2011.03.001 · Cited by 37
Kajaste‐Rudnitski, A., & Naldini, L. (2015) · Human Gene Therapy · doi:10.1089/hum.2015.036 · Cited by 40
Vazquez, S. E., Inlay, M. A., & Serwold, T. F. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.04.001 · Cited by 37
Woeckel, V. J., Eijken, M., van de Peppel, J., Chiba, H., van der Eerden, B. C. J., & van Leeuwen, J. P. T. M. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.23009 · Cited by 39
“Adhesion of HSCs to osteoblasts derived from ANXA2-deficient mice was significantly impaired compared to osteoblasts obtained from wild type animals (Jung et al., 2010).”
BackgroundInfluentialBosutinib: a dual SRC/ABL kinase inhibitor for the treatment of chronic myeloid leukemia
Keller, G., Schafhausen, P., & Brümmendorf, T. H. (2009) · Expert Review of Hematology · doi:10.1586/ehm.09.42 · Cited by 42
Dormancy in the stem cell niche
Sottocornola, R., & Celso, C. L. (2012) · Stem Cell Research & Therapy · doi:10.1186/scrt101 · Cited by 38
Kelly, L. S., Darden, D. B., Fenner, B. P., Efron, P. A., & Mohr, A. M. (2020) · Shock · doi:10.1097/shk.0000000000001699 · Cited by 40
“IFN-a induces HSPC proliferation and upregulation of target genes via IFNa/b receptor using STAT1 and PKB/Akt signaling pathways (20).”
BackgroundInfluentialKing, K. Y., Matatall, K. A., Shen, C.-C., Goodell, M. A., Swierczek, S. I., & Prchal, J. T. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.013 · Cited by 38
Uyangaa, E., Kim, J. H., Patil, A. M., Choi, J., Kim, S. B., & Eo, S. K. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005256 · Cited by 40
The Role of the Bone Marrow Microenvironment in the Response to Infection
Johnson, C. B., Zhang, J., & Lucas, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585402 · Cited by 39
Context Is Key: Delineating the Unique Functions of IFNα and IFNβ in Disease
Fox, L. E., Locke, M. C., & Lenschow, D. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.606874 · Cited by 40
Braig, M., Pällmann, N., Preukschas, M., Steinemann, D., Hofmann, W. A., Gompf, A., Streichert, T., Braunschweig, T. A., Copland, M., Rudolph, K. L., et al. (2014) · Leukemia · doi:10.1038/leu.2014.95 · Cited by 37
Anti-metastatic functions of type 1 interferons: Foundation for the adjuvant therapy of cancer
Ortiz, A., & Fuchs, S. Y. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.010 · Cited by 38
Ehninger, A., Boch, T., Medyouf, H., Müdder, K., Orend, G., & Trumpp, A. (2014) · Blood · doi:10.1182/blood-2013-10-533711 · Cited by 39
Self-citationSui, W., Hou, X., Che, W.-T., Chen, J., Ou, M., Xue, W., & Dai, Y. (2013) · Clinical Immunology · doi:10.1016/j.clim.2013.05.014 · Cited by 36
Sepsis-Induced Thymic Atrophy Is Associated with Defects in Early Lymphopoiesis
Kong, Y., Li, Y., Zhang, W., Yuan, S., Winkler, R., Kröhnert, U., Han, J., Lin, T., Zhou, Y. J., Miao, P., et al. (2016) · Stem Cells · doi:10.1002/stem.2464 · Cited by 35
Cancer Stem Cells in Squamous Cell Carcinoma
Jian, Z., Strait, A. A., Jimeno, A., & Wang, X. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.07.033 · Cited by 35
“Indeed, rescuing hematopoietic SCs from a quiescent state increased their sensitivity to 5- fluorouracil (Essers et al., 2009).”
BackgroundIdentification of immune-activated hematopoietic stem cells
Bujanover, N., Goldstein, O., Greenshpan, Y., Turgeman, H., Klainberger, A., Scharff, Y., & Gazit, R. (2018) · Leukemia · doi:10.1038/s41375-018-0220-z · Cited by 39
Akrami, M., Menzies, R. J., Chamoto, K., Miyajima, M., Suzuki, R., Sato, H., Nishii, A., Tomura, M., Fagarasan, S., & Honjo, T. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010981117 · Cited by 38
Huo, Y., Wu, L., Pang, A., Li, Q., Hong, F., Zhu, C., Yang, Z., Dai, W., Zheng, Y., Meng, Q., et al. (2023) · Science Immunology · doi:10.1126/sciimmunol.abn6429 · Cited by 40
Cellular aging leads to functional heterogeneity of hematopoietic stem cells: a modeling perspective
Glauche, I., Thielecke, L., & Roeder, I. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00692.x · Cited by 37
“Under the assumption that aging is sufficiently described as a cumulative, mitosis-related decrease of individual stem cell functionality, our model furthermore predicts that the overall (organismal) aging should be accelerated by the administration of cell cycle-activating drugs such as G-CSF (Morrison et al., 1997)…”
BackgroundRuppert, R., Moser, M., Sperandio, M., Rognoni, E., Orban, M., Liu, W.-H., Schulz, A., Oostendorp, R. A. J., Maßberg, S., & Fässler, R. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20150269 · Cited by 36
“To test whether HSCs are hyperactive, we first determined the sensitivity of K3+/+ and K3/ chimeras to the cytostatic drug 5-fluorouracil (5-FU), which eliminates cycling, but not quiescent, HSCs (Essers et al., 2009).”
BackgroundInducible Gene and shRNA Expression in Resident Hematopoietic Stem Cells In Vivo
Laurenti, E., Barde, I., Verp, S., Offner, S., Wilson, A., Quenneville, S., Wiznerowicz, M., MacDonald, H. R., Trono, D., & Trumpp, A. (2010) · Stem Cells · doi:10.1002/stem.460 · Cited by 41
Self-citationKim, D. H. (., Kong, J. H., Byeun, J. Y., Jung, C. W., Xu, W., Liu, X., Kamel‐Reid, S., Kim, Y.-K., Kim, H., & Lipton, J. H. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1638 · Cited by 35
Niu, H., Fang, G., Tang, Y., Xie, L., Yang, H., Morel, L. M., Diamond, B., & Zou, Y.-R. (2013) · Blood · doi:10.1182/blood-2012-05-433755 · Cited by 37
Eosinophil-derived CCL-6 impairs hematopoietic stem cell homeostasis
Zhang, C., Yi, W., Li, F., Du, X., Wang, H., Wu, P., Peng, C., Luo, M., Hua, W., Wong, C. C. L., et al. (2018) · Cell Research · doi:10.1038/cr.2018.2 · Cited by 35
The cGAS-STING Pathway in Hematopoiesis and Its Physiopathological Significance
Liao, W., Du, C., & Wang, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.573915 · Cited by 38
“Conversely, inhibition of STAT1, Akt/mTOR, or Sca-1 will cause HSCs to become insensitive to IFN-I stimulation, indicating that STAT1, Akt/mTOR, and Sca-1 mediate the effects of IFN-I (67, 68).”
BackgroundRole of Type I Interferon Receptor Signaling on NK Cell Development and Functions
Guan, J., Miah, S. M. S., Wilson, Z., Erick, T. K., Banh, C., & Brossay, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111302 · Cited by 34
“This is consistent with previous findings in hematopoietic stem cells (HSCs) showing that type I IFN induce proliferation of HSCs [20,21].”
ResultZhu, Y., Karakhanova, S., Huang, X., Deng, S. P., Werner, J., & Bazhin, A. V. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.03.020 · Cited by 38
TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes
Swiecki, M. K., McCartney, S. A., Wang, Y., & Colonna, M. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.0311166 · Cited by 37
“tion of dormant hematopoietic stem cells [17] are also in-”
BackgroundPorter, S. N., Cluster, A. S., Yang, W., Busken, K. A., Patel, R. M., Ryoo, J., & Magee, J. A. (2016) · eLife · doi:10.7554/elife.18882 · Cited by 35
IRF1 regulates self-renewal and stress responsiveness to support hematopoietic stem cell maintenance
Nilsson, A. R., Xian, H., Shalapour, S., Cammenga, J., & Karin, M. (2023) · Science Advances · doi:10.1126/sciadv.adg5391 · Cited by 35
Systemic responses during local viral infections: type I IFNs sound the alarm
López, C. B., & Hermesh, T. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.06.003 · Cited by 38
Towards a Better Understanding of Cohesin Mutations in AML
Cuartero, S., Innes, A. J., & Merkenschlager, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00867 · Cited by 34
A complex proinflammatory cascade mediates the activation of HSCs upon LPS exposure in vivo
Demel, U. M., Lutz, R., Sujer, S., Demerdash, Y., Sood, S., Grünschläger, F., Kuck, A., Werner, P., Blaszkiewicz, S., Uckelmann, H. J., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021006088 · Cited by 37
Self-citationSevere hematopoietic stem cell inflammation compromises chronic granulomatous disease gene therapy
Sobrino, S., Magnani, A., Semeraro, M., Martignetti, L., Cortal, A., Denis, A., Couzin, C., Pïcard, C., Bustamante, J. C., Magrin, E., et al. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.100919 · Cited by 36
Eit, R. E., Iskandarani, A., Saliba, J. L., Jabbour, M. N., Mahfouz, R. A., Bitar, N., El-Ayoubi, H. R., Zaatari, G. S., Mahon, F., de Thé, H., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28427 · Cited by 33
Modeling the Prostate Stem Cell Niche: An Evaluation of Stem Cell Survival and Expansion In Vitro
Lang, S., Anderson, E. L., Fordham, R. P., & Collins, A. T. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0291 · Cited by 33
“In addition, we also tested FGF2 because it can support sphere growth in other tissues [20], IFNα because it can activate dormant hematopoietic stem cells (HSCs) [21], and IL-6 because we have previously shown it to be up-regulated in prostate cancer stem and committed cells and therefore represents a candidate for st…”
High throughput screening of small molecule libraries for modifiers of radiation responses
Kim, K., Damoiseaux, R. D., Norris, A. J., Rivina, L., Bradley, K. A., Jung, M. E., Gatti, R. A., Schiestl, R. H., & McBride, W. H. (2011) · International Journal of Radiation Biology · doi:10.3109/09553002.2011.560994 · Cited by 33
“Recently IFN-α has been shown to activate dormant hematopoietic stem cells (Essers et al. 2009), suggesting a pathway that could link the sense of “danger” to hematopoiesis.”
BackgroundKlimmeck, D., Cabezas‐Wallscheid, N., Reyes, A., von Paleske, L., Renders, S., Hansson, J., Krijgsveld, J., Huber, W. K., & Trumpp, A. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.08.012 · Cited by 39
“…network presented in this study significantly extends our knowledge of distinct self-protective mechanisms elevated in HSPCs already at steady state and is in agreement with the recently observed reversible activation of HSCs under conditions of stress (Essers et al., 2009; Trumpp et al., 2010).”
ResultSelf-citationFight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis
Croker, B. A., Silke, J., & Gerlic, M. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000148 · Cited by 35
Bjørn, M. E., de Stricker, K., Kjær, L., Ellemann, K., & Hasselbalch, H. C. (2014) · Leukemia Research Reports · doi:10.1016/j.lrr.2014.05.003 · Cited by 32
“Furthermore, IFN-a2 also activates dormant stem cells [6] and mobilizes them to be targets for potent JAK1-2 inhibition.”
BackgroundKim, Y., Lee, D., Lee, J.-H., Lee, S., & Lawler, S. E. (2019) · PLoS ONE · doi:10.1371/journal.pone.0211041 · Cited by 38
Neutrophil Maturation and Survival Is Controlled by IFN-Dependent Regulation of NAMPT Signaling
Siakaeva, E., Pylaeva, E., Spyra, I., Bordbari, S., Höing, B., Kürten, C. H. L., Lang, S., & Jabłońska, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225584 · Cited by 44
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering
Piras, F., & Kajaste‐Rudnitski, A. (2020) · Gene Therapy · doi:10.1038/s41434-020-0175-3 · Cited by 35
Tu, Z., Wang, C., Davis, A. K., Hu, M., Zhao, C., Xin, M., Lu, Q. R., & Zheng, Y. (2021) · Blood · doi:10.1182/blood.2020009997 · Cited by 32
Follicular T Cells are Clonally and Transcriptionally Distinct in B Cell-Driven Autoimmune Disease
Akama‐Garren, E. H., van den Broek, T., Simoni, L., Castrillon, C. E., van der Poel, C. E., & Carroll, M. C. (2020) · Nature Communications · doi:10.1038/s41467-021-27035-8 · Cited by 33
Emmrich, S., Trapp, A., Zakusilo, F. T., Straight, M. E., Ying, K., Tyshkovskiy, A., Mariotti, M., Gray, S., Zhang, Z., Drage, M. G., et al. (2022) · The EMBO Journal · doi:10.15252/embj.2021109694 · Cited by 36
“In response to IFN α through its cognate receptor IFNAR1, HSCs exit dormancy and become activated (Essers et al , 2009), while the transcriptional suppressor of type I IFN signaling IRF2 prevents stem cell exhaustion (Sato et al , 2009).”
Diverse roles of lung macrophages in the immune response to influenza A virus
Li, H., Wang, A., Zhang, Y., & Wei, F. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1260543 · Cited by 42
“For instance, following influenza virus infection, AMs-produced IFN-I plays a role of immune protection through the promotion of hematopoietic cell proliferation and differentiation (Essers et al., 2009; Sato et al., 2009) and the upregulation of chemokine (C-C motif) ligand 2 (CCL2), which is necessary for CCR2-depen…”
Chronic Exposure to Type-I IFN under Lymphopenic Conditions Alters CD4 T Cell Homeostasis
Saout, C. L., Hasley, R. B., Imamichi, H., Tcheung, L., Hu, Z., Luckey, M. A., Park, J., Durum, S. K., Smith, M., Rupert, A. W., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003976 · Cited by 33
“Mice were treated with therapeutic doses of 10,000 U of rmIFN-a, daily (,4610 U/kg/day), for one month [25–27].”
BackgroundMethodThe role of stat1b in zebrafish hematopoiesis
Song, H., Yan, Y., Titus, T. A., He, X., & Postlethwait, J. H. (2011) · Mechanisms of Development · doi:10.1016/j.mod.2011.08.004 · Cited by 36
“Recent studies showed that IFN treatments stimulated dormant HSCs in mice and that the effect depended on Stat1 (Baldridge et al., 2010; Essers et al., 2009; Sato et al., 2009), but the roles of STAT1-alpha and STAT1-beta forms were not tested independently.”
Glauche, I., Horn, K., Horn, M., Thielecke, L., Essers, M. A. G., Trumpp, A., & Roeder, I. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.142 · Cited by 38
“In Essers et al (2009), it has been demonstrated that IFNa treatment (at time point 0) increases the fraction of dividing HSCs in a B6 mouse model within a 24 h interval from 20 up to 70%.”
BackgroundMethodResultInfluentialSelf-citationGenetic control of quiescence in hematopoietic stem cells
Yamada, T., Park, C. S., & Lacorazza, H. D. (2013) · Cell Cycle · doi:10.4161/cc.25416 · Cited by 36
Retrotransposons are co-opted to activate hematopoietic stem cells and erythropoiesis
Phan, J., Chen, B., Zhao, Z., Allies, G., Iannaccone, A., Paul, A., Cansiz, F., Spina, A., Leven, A., Gellhaus, A., et al. (2024) · Science · doi:10.1126/science.ado6836 · Cited by 35
Systemic inflammation impairs myelopoiesis and interferon type I responses in humans
Keramati, F., Leijte, G. P., Bruse, N., Grondman, I., Habibi, E., Ruiz-Moreno, C., Megchelenbrink, W., van Ton, A. M. P., Heesakkers, H., Bremmers, M. E. J., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02136-4 · Cited by 38
“IFN-I induction in murine HSCs can activate HSCs to proliferate and thereby contribute to emergency myelopoiesis, while inducing HSC exhaustion in the long term 29–31 .”
Tran, D. D. H., Saran, S., Dittrich‐Breiholz, O., Williamson, A. J. K., Klebba-Färber, S., Koch, A., Kracht, M., Whetton, A. D., & Tamura, T. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.409 · Cited by 31
Melo, J. V., & Ross, D. M. (2011) · Hematology · doi:10.1182/asheducation-2011.1.136 · Cited by 32
At the crossroads of cancer stem cells and targeted therapy resistance
Wang, A., Qu, L., & Wang, L. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.10.039 · Cited by 31
C/EBPβ isoforms sequentially regulate regenerating mouse hematopoietic stem/progenitor cells
Satō, A., Kamio, N., Yokota, A., Hayashi, Y., Tamura, A., Miura, Y., Maekawa, T., & Hirai, H. (2020) · Blood Advances · doi:10.1182/bloodadvances.2018022913 · Cited by 35
Ramabadran, R., Wang, J. H., Reyes, J. M., Guzman, A. G., Gupta, S., Rosas, C., Brunetti, L., Gundry, M. C., Tovy, A., Long, H., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01109-9 · Cited by 35
Bhattarai, G., Shrestha, S. K., Sim, H., Lee, J., & Kook, S. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01149-z · Cited by 37
Targeting Chronic Myeloid Leukemia Stem Cells
Helgason, G. V., Young, G. A. R., & Holyoake, T. L. (2010) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-010-0043-0 · Cited by 30
Ahmed, W. B., & Etten, R. A. V. (2013) · Hematology · doi:10.1182/asheducation-2013.1.189 · Cited by 31
Development of platelets during steady state and inflammation
Müller‐Newen, G., Stope, M. B., Kraus, T., & Ziegler, P. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ru0916-391rr · Cited by 30
Interferon-α Promotes the Expression of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma
Ma, H., Jin, S., Yang, W., Tian, Z., Liu, S., Wang, Y., Zhou, G., Zhao, M., Gvetadze, S. R., Zhang, Z., et al. (2017) · Journal of Cancer · doi:10.7150/jca.19486 · Cited by 30
“Pre-treated/primed with IFNα can awaken dormant haematopoietic stem cells in vivo [15].”
BackgroundCheckpoint kinase 1 is essential for fetal and adult hematopoiesis
Schuler, F., Afreen, S., Manzl, C., Häcker, G. A., Erlacher, M., & Villunger, A. (2019) · EMBO Reports · doi:10.15252/embr.201847026 · Cited by 32
Trained Immunity and Cardiometabolic Disease: The Role of Bone Marrow
Mitroulis, I., Hajishengallis, G., & Chavakis, T. (2020) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.120.314215 · Cited by 32
Inhibition of pyrimidine biosynthesis targets protein translation in acute myeloid leukemia
So, J., Lewis, A. C., Smith, L. K., Stanley, K. L., Franich, R. L., Yoannidis, D., Pijpers, L., Domínguez, P. M., Hogg, S. J., Vervoort, S. J., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202115203 · Cited by 32
“…in both RUNX1-RUNX1T1 and I1DN models, we observed increased surface expression of Sca1, a marker associated not only with ª 2022 The Authors EMBO Molecular Medicine 14: e15203 | 2022 3 of 20 stemness but also with Type I interferon (IFN) signaling (Essers et al, 2009; Appendix Fig S1C and E).”
BackgroundThe phenotype of the most common human ADAR1p150 Zα mutation P193A in mice is partially penetrant
Liang, Z., Chalk, A. M., Taylor, S., Goradia, A., Heraud-Farlow, J. E., & Walkley, C. R. (2023) · EMBO Reports · doi:10.15252/embr.202255835 · Cited by 34
“We also assessed activation of the ISG response by assessing the expression of Sca-1, an ISG induced in response to a loss of ADAR1 (Essers et al , 2009; Hartner et al , 2009; Heraud-Farlow et al , 2017).”
Identifying leukemia stem cells – Is it feasible and does it matter?
Lutz, C., Hoang, V. T., Buss, E. C., & Ho, A. D. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.07.014 · Cited by 30
“mediated induction of cell cycle entry rendering these cells susceptible to 5-FU treatment [54].”
Background
Metadata
- Authors
- Essers, M. A. G., Offner, S., Blanco-Bose, W. E., Waibler, Z., Kalinke, U., Duchosal, M. A., & Trumpp, A.
- Affiliations
- German Cancer Research Center (DE)
- École Polytechnique Fédérale de Lausanne (CH)
- Paul Ehrlich Institut (DE)
- Center for Experimental and Clinical Infection Research (DE)
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Trumpp, Andreas
- Venue
- Nature
- Published
- 2009-02-11
- Volume
- 458
- Issue
- 7240
- Pages
- 904-908
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011059916
- Cited by
- 1,368
- References
- 31
- Citations by year
- 2026: 59 · 2025: 72 · 2024: 67 · 2023: 96 · 2022: 91 · 2021: 99 · 2020: 90 · 2019: 72 · 2018: 68 · 2017: 81 · 2016: 82 · 2015: 60 · 2014: 99 · 2013: 80 · 2012: 71
- FWCI
- 56.02
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Zenodo (CERN European Organization for Nuclear Research) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Keywords
- hematopoietic stem cells, interferon-alpha, HSC proliferation, STAT1, Sca-1, IFNAR, type I interferon, 5-fluorouracil, leukemia, cancer stem cells, chemosensitization
- MeSH terms
- Animals, Antigens, Ly, Cell Count, Cell Cycle, Fluorouracil, Hematopoietic Stem Cells, Membrane Proteins, Mice, Inbred C57BL, Phosphorylation, Signal Transduction, Up-Regulation, Interferon-alpha, Cell Proliferation, STAT1 Transcription Factor, Mice, Receptor, Interferon alpha-beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.